Immunotherapy and experimental approaches for metastatic melanoma

被引：30

作者：

Atkins, MB

机构：

[1] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Melanoma & Biol Therapy Programs, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1998年 / 12卷 / 04期

关键词：

D O I：

10.1016/S0889-8588(05)70029-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This article reviews the clinical investigations involving recombinant cytokines (either alone or in combination with adoptive immunotherapy, toxicity reduction agents, or cytotoxic chemotherapy), vaccines, monoclonal antibodies or antibody conjugates, and gene therapy. These various approaches are reviewed for their current and potential roles in curing metastatic melanoma.

引用

页码：877 / +

页数：27

共 154 条

[21] Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone [J].

Bianchi, M ;

Bloom, O ;

Raabe, T ;

Cohen, PS ;

Chesney, J ;

Sherry, B ;

Schmidtmayerova, H ;

Calandra, T ;

Zhang, XN ;

Bukrinsky, M ;

Ulrich, P ;

Cerami, A ;

Tracey, KJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :927-936

[22] AN INHIBITOR OF MACROPHAGE ARGININE TRANSPORT AND NITRIC-OXIDE PRODUCTION (CNI-1493) PREVENTS ACUTE-INFLAMMATION AND ENDOTOXIN LETHALITY [J].

BIANCHI, M ;

ULRICH, P ;

BLOOM, O ;

MEISTRELL, M ;

ZIMMERMAN, GA ;

SCHMIDTMAYEROVA, H ;

BUKRINSKY, M ;

DONNELLEY, T ;

BUCALA, R ;

SHERRY, B ;

MANOGUE, KR ;

TORTOLANI, AJ ;

CERAMI, A ;

TRACEY, KJ .

MOLECULAR MEDICINE, 1995, 1 (03) :254-266

[23] INVIVO ANTITUMOR-ACTIVITY OF COMBINATIONS OF INTERFERON-ALPHA AND INTERLEUKIN-2 IN A MURINE MODEL - CORRELATION OF EFFICACY WITH THE INDUCTION OF CYTOTOXIC-CELLS RESEMBLING NATURAL-KILLER-CELLS [J].

BRUNDA, MJ ;

BELLANTONI, D ;

SULICH, V .

INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (03) :365-371

[24]

Bystryn J C, 1995, Recent Results Cancer Res, V139, P337

[25] Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity [J].

Celluzzi, CM ;

Mayordomo, JI ;

Storkus, WJ ;

Lotze, MT ;

Falo, LD .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :283-287

[26] PHASE IB TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COMBINED WITH MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATIC MELANOMA [J].

CHACHOUA, A ;

ORATZ, R ;

LIEBES, L ;

ALTER, RS ;

FELICE, A ;

PEACE, D ;

VILCEK, J ;

BLUM, RH .

JOURNAL OF IMMUNOTHERAPY, 1994, 16 (02) :132-141

[27]

CHAPMAN PB, 1994, VACCINE RES, V3, P59

[28]

CHAPMAN PB, 1998, CUTANEOUS MELANOMA, P419

[29] GANGLIOSIDE GD2 SPECIFIC MONOCLONAL ANTIBODY-3F8 - A PHASE-I STUDY IN PATIENTS WITH NEUROBLASTOMA AND MALIGNANT-MELANOMA [J].

CHEUNG, NKV ;

LAZARUS, H ;

MIRALDI, FD ;

ABRAMOWSKY, CR ;

KALLICK, S ;

SAARINEN, UM ;

SPITZER, T ;

STRANDJORD, SE ;

COCCIA, PF ;

BERGER, NA .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) :1430-1440

[30]

COIT D, 1988, P AN M AM SOC CLIN, V7, P248

← 1 2 3 4 5 6 7 8 9 10 →